Top Story

Retreatment of HCV patients with DAAs demonstrates high SVR rates

May 4, 2015

Research presented at the 2015 International Liver Congress may be the first to demonstrate a high sustained virologic response rate in patients with hepatitis C virus infection who were retreated with direct-acting antiviralsafter previously failing therapy with these newer regimens.

“[Direct-acting antivirals (DAAs)] have dramatically improved the treatment of hepatitis C, but retreatment strategies for patients who have failed to achieve sustained virologic response (SVR) with combination DAAs have not been studied,” Eleanor M.P. Wilson, MD, of the Critical Care Medicine Department at the NIH, and colleagues wrote.

Statins improve SVR rates, lower cirrhosis, HCC risk in HCV therapy In the Journals

Statins improve SVR rates, lower cirrhosis, HCC risk in HCV therapy

May 4, 2015
The addition of statins to hepatitis C virus infection antiviral therapy showed the progression of liver fibrosis and reduced hepatocellular carcinoma and cirrhosis…
In the Journals

Failure risk higher in certain patients after single surgical debridement for septic joints

May 4, 2015
Most cases of septic joints were effectively managed after a single surgical debridement; however, patients with a history of inflammatory arthropathy, involvement of…
In the Journals

Hospitals support antimicrobial stewardship, but practice falls short

May 4, 2015
An overwhelming majority of lead infection control coordinators at hospitals see the need for antimicrobial stewardship, yet nearly half of their facilities do not…
In the Journals

Azithromycin ineffectively treats macrolide-resistant M. genitalium

May 3, 2015
Azithromycin appeared to have a high rate of failure among patients infected with Mycoplasma genitalium who demonstrated pre-treatment macrolide resistance, according…
More News Headlines »
CME
Infectious Disease Case Consults

The Patient at Risk for HIV Infection

No commercial support for this activity.

This CME activity will focus on the utilization of PrEP in patients at risk for developing HIV infection supplemented…
More »
Meeting News Coverage Video
VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

VIDEO: Effectiveness of inactivated vs. live flu vaccine currently unclear

April 24, 2015
BETHESDA, Md. — Richard K. Zimmerman, MD, of the University of Pittsburgh, explains the results of his study…
More »
CME
j526

Regimen Selection in HIV: Considering New Options to Optimize Outcomes

This activity is supported by an educational grant from Gilead Sciences Medical Affairs.

More than two decades into the antiretroviral therapy (ART) era, there are numerous options for HIV treatment. The goal…
More »
morganatic-roan